LifeMD, Inc. (LFMDP) stock
LFMDPNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMD
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 10/3099% above fair value
$21.65+0.13 (+0.60%)
Close on Oct 30, 2026Market cap $110.38MP/E –Yield –
LifeMD pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
LifeMD's pe ratio was 535.3× on Oct 19, 2026, against 0.0× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 535.3× | +505.3 |
| 2018 | Jul 31, 2018 | 30.0× | +30.0 |
| 2016 | Jan 29, 2016 | 0.0× | +0.0 |
| 2015 | Dec 31, 2015 | 0.0× | – |